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Langerhans cell histiocytosis (LCH) is a spectrum of clinicopathological condition caused by the reactive proliferation of marrow-derived immature myeloid 
dendritic cells of the skin and visceral organs. The annual 
incidence in the pediatric population (in <15 years) is 4–5 cases 
per million per year, and more than 50% of cases are diagnosed 
in the first 3 years of life with male predominance [1]. Although 
exact etiology of LCH is yet to be completely understood, 
environmental factors, viral infections, and smoking in adult 
trigger this reactive disease, and loss of heterozygosity and 
instability of chromosome and elevated oncogene products are 
more persuasive evidence of neoplasia [2]. Clinical presentation 
varies from self-healing lesions to life-threatening disseminated 
disease. It may affect any organ, but bone (80%), skin (33%), 
and the pituitary gland (25%) are most commonly affected in 
children [3]. Diagnosis of LCH is based on synthetic analysis of 
clinical manifestation, imaging, and histopathological features. 
Prognosis depends on age of onset, risk organ involvement, and 
the rate of progression [4]. Here, we have described a case of 
multisystem multifocal LCH.
CASE REPORT
An 11-month-old female infant born of non-consanguineous 
parents presented with moderate- to high-grade fever, pallor, and 
skin lesion over the abdomen and scalp. On further inquiry, she 
had a history of failure to thrive and bilateral ear discharge but no 
bleeding manifestation, respiratory, or urinary complaint. She had 
an uneventful birth history with appropriate birth weight. She was 
developmentally normal and immunized as per age. Family history 
was not significant. On physical examination, her vitals were 
stable except she was febrile and had severe pallor (Hemoglobin 
[Hb]-3.9 g%). She had multiple erythematous, crusted, scaly 
hypopigmented macules, and shiny colored papules over the 
scalp, forehead, and trunk between multiple petechial spots over 
the trunk and perineal region (Fig. 1a and b). Nails were distally 
erythematous and she had no signs of vitamin deficiency or bony 
tenderness and swelling. No ocular abnormalities were found. The 
liver was palpable 4 cm and spleen 2 cm below costal margin.
Laboratory investigation revealed persistent pancytopenia 
(Hb-3.9 g%, total leukocyte count-4500/cumm, and platelet 
39,000/cumm) on multiple occasions with normal coagulation 
profile. Liver function, renal function, and electrolytes were 
within the normal limit. Dengue antigen test, tuberculin test, 
and solubility test were negative, and malarial parasites were not 
detected on peripheral smear. Chest radiograph and ultrasound 
abdomen were within normal limits except hepatosplenomegaly, 
whereas bone marrow examination and serum ferritin were 
within normal limits. Computed tomography of the brain reveals 
calvarial intradiploic soft tissue density lesion predominantly 
hypodense of average HU 25, of average size 19.5 mm×7.7 mm 
noted in the right high parietal region causing underlying bony 
defect (punched out lesion) (Fig. 2a and b). Skeletal survey, 
including whole bone scan, did not reveal any abnormality.
A biopsy from skin lesion showed focal thinning of the 
epidermis with crust formation. Superficial dermis showed 
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dilatation of capillaries with the extravasation of red blood 
cells and infiltration by large abnormal cells with moderate 
amount of eosinophilic cytoplasm and multilobulated tumor 
cells, occasional admixture with eosinophils and lymphocytes 
that suggested LCH (Fig. 3). On immunohistochemistry, the 
cells were found to be CD1a and S-100 positive. Based on the 
clinicopathological, radiological, and immunohistochemistry, 
the diagnosis of multifocal multisystem LCH was done. The 
infant was treated with vinblastine and prednisolone. In addition, 
antipyretics, antibiotics, blood, and platelet transfusions were 
prescribed. In spite of proper counseling and appropriate therapy, 
the parents were not willing for further treatment and the patient 
was discharged against medical advice.
DISCUSSION
The old terminology “Liechtenstein’s histiocytosis X” is now 
replaced by LCH. It is a rare clonal proliferation disorder of 
antigen presenting cells which could be present at any age right 
from the neonate to old age, but most often it is diagnosed in the 
first 3 years of life. The annual incidence in children <15 years is 
4–5 cases per million per year with male predominance [1,5,6]. 
Historically, it was described as eosinophilic granuloma 
characterized by the presence of one or more lytic bone lesion; 
Hand–Schuller–Christian disease, comprising the clinical triad 
of bone defects, exophthalmos, and polyuria; and Letterer–
Siwe disease which is a disseminated disorder marked by 
hepatosplenomegaly, lymphadenopathy, skin rash, bone lesion, 
and hematological compromise.
Recently, stratification system was adopted by Histiocytosis 
Society and classified it into single system disease (SS-LCH), 
which occurs in about two-third of pediatric age group, and can 
be further subdivided into single site and multiple site forms and 
multisystem (MS-LCH), in which more than two organ system are 
involved at the time of diagnosis. Multisystem LCH is subdivided 
into low- and high-risk forms. In high-risk forms, multiples organs 
are involved such as bone marrow, liver, spleen, and lung [1,7]. 
The present case had liver, spleen, bone, and hematopoietic system 
involvement and thus classified as multisystem high-risk form.
The etiology of LCH has been debatable till date whether it is a 
neoplastic or of reactive nature. It has been described as neoplastic 
process due to monoclonal proliferation, loss of heterozygosity 
and instability of chromosome, elevated level of oncogene 
product, and recent report of BRAF V600E oncogenic mutation. 
However, the hypothesis of reactive inflammatory disorder 
resulting from dysregulation of immune system by various trigger 
like environmental factors, viruses (cytomegalovirus and herpes 
virus), and smoking in adult lung LCH are supportive as LCH is 
known to release a number of inflammatory chemokine receptors, 
ligands, macrophages, inflammatory proteins, monocytes 
chemoattractant proteins, and interleukins. These chemokines 
are playing an important role for the recruitment of circulating 
immature dendritic cell as well as other immune cells, and this 
“cytokine storm” stimulates the autocrine and paracrine cascade 
and explains a number of clinical symptoms including fever and 
failure to thrive [1,4,7].
The diagnosis of LCH is based on clinical presentation, 
imaging, and histopathological findings. Pathologically, LCH is a 
granulomatous lesion containing multinucleated Langerhans cells, 
eosinophils, macrophages, and histiocytes. The pentilaminal, 
“racquet-shaped” cytoplasmic granules (Birbeck granules) 
is a gold standard for the diagnosis on electron microscopic 
examination. However, cell surface markers such as CD1a, S100, 
and CD207 support the diagnosis on immunohistochemistry of 
biopsy specimen [8,9]. Nowadays, highly specific and sensitive 
monoclonal antibody against CD207 (Langerhans), which is 
important for the formation of Birbeck granules, has become 
commercially available. We confirmed the diagnosis of LCH 
on histopathological observation and immunohistochemistry 
staining with CD1a and S100.
Figure 1: (a and b) Seborrheic dermatitis of scalp and infant with 
skin lesion
Figure 3: Histopathological finding on skin biopsy
a b
Figure 2: (a and b) Bony defect of parietal scalp bone and punched 
out lesion on CT brain
ba
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Management of multisystem LCH is a challenge as mortality is 
high in young children with involvement of risk organs and bouts of 
reactivation of disease. Several international protocols have been 
designed for MS-LCH, but the most popular regimen is vinblastine 
or etoposide and steroid. Other options include cladribine and 
cytarabine or hematopoietic stem cell transplantation [9]. The 
use of radiation therapy is controversial. The patient was treated 
with vinblastine and steroid, but unfortunately, parents did not 
complete the regimen, and we could not assess the effectiveness.
CONCLUSION
Due to extreme clinical heterogeneity, LCH can present with varied 
presentation, and thus, high index of suspicion is necessary to make 
timely diagnosis and treatment to minimize the frustration felt by 
parents/patients. Proper and effective counseling paired with family 
support is of paramount importance to adhere to the treatment plan.
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